Positron Emission Tomography in Animal Models of Alzheimer’s Disease Amyloidosis: Translational Implications

Código QR

Positron Emission Tomography in Animal Models of Alzheimer’s Disease Amyloidosis: Translational Implications

Animal models of Alzheimer’s disease amyloidosis that recapitulate cerebral amyloid-beta pathology have been widely used in preclinical research and have greatly enabled the mechanistic understanding of Alzheimer’s disease and the development of therapeutics. Comprehensive deep phenotyping of the pa...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Ruiqing Ni
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	Alzheimer’s disease amyloid-beta animal model astrocyte blood–brain barrier imaging Medicine R Pharmacy and materia medica RS1-441
Acceso en línea:	https://doaj.org/article/b94e0aa7e39d4902b25977fc04b4c41e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Extensive frontal focused ultrasound mediated blood–brain barrier opening for the treatment of Alzheimer’s disease: a proof-of-concept study
por: So Hee Park, et al.
Publicado: (2021)

Alzheimer disease: 100 years later
por: Puglielli MD,Luigi, et al.
Publicado: (2001)

Effect of Curcumin on Beta-Amyloid Plasma Level in Alzheimer Disease: A Systematic Review and Meta-analysis
por: Shima Mehrabadi, et al.
Publicado: (2021)

Salivary Biomarkers in Alzheimer´s Disease
por: Santos,Gustavo A. A, et al.
Publicado: (2020)

Liposome based drug delivery as a potential treatment option for Alzheimer’s disease
por: Carely Hernandez, et al.
Publicado: (2022)

Histidines 13 and 14 in the Aβ sequence are targets for inhibition of Alzheimer's disease Aβ ion channel and cytotoxicity
por: DÍAZ,JUAN CARLOS, et al.
Publicado: (2006)

To evaluate the role of positron emission tomography-computerized tomography in initial staging of carcinoma breast
por: Anju Kansal, et al.
Publicado: (2021)

Role of Lipocalin-2 in Amyloid-Beta Oligomer-Induced Mouse Model of Alzheimer’s Disease
por: Heeyoung Kang, et al.
Publicado: (2021)

Wheat germ agglutinin-conjugated liposomes incorporated with cardiolipin to improve neuronal survival in Alzheimer’s disease treatment
por: Kuo YC, et al.
Publicado: (2017)

Evaluation of Amyloid Polypeptide Aggregation Inhibition and Disaggregation Activity of A-Type Procyanidins
por: Taisei Tanaka, et al.
Publicado: (2021)

Diagnostic Utility of Integrated11C-Pittsburgh Compound B Positron Emission Tomography/Magnetic Resonance for Cerebral Amyloid Angiopathy: A Pilot Study
por: Yan Chang, et al.
Publicado: (2021)

Atorvastatin attenuates the production of IL-1β, IL-6, and TNF-α in the hippocampus of an amyloid β1-42-induced rat model of Alzheimer’s disease
por: Zhang YY, et al.
Publicado: (2013)

Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases
por: Claudia Riccardi, et al.
Publicado: (2021)

Administration of anti-ERMAP antibody ameliorates Alzheimer’s disease in mice
por: Haiyan Liu, et al.
Publicado: (2021)

APOE GENE POLYMORPHISM: THE IMPACT OF APOE4 ALLELE ON SYSTEMIC INFLAMMATION AND ITS ROLE IN THE PATHOGENESIS OF ALZHEIMER’S DISEASE
por: I. K. Malashenkova, et al.
Publicado: (2018)

Perspectivas en la prevención y tratamiento farmacológico de la enfermedad de Alzheimer
por: Archibaldo Donoso,S, et al.
Publicado: (2009)

[<sup>18</sup>F]2-Fluoro-2-deoxy-sorbitol PET Imaging for Quantitative Monitoring of Enhanced Blood-Brain Barrier Permeability Induced by Focused Ultrasound
por: Gaëlle Hugon, et al.
Publicado: (2021)

An insight into Alzheimer’s disease and its on-setting novel genes
por: Jaanaky Vigneswaran, et al.
Publicado: (2021)

Microglia and Astrocytes in Alzheimer’s Disease in the Context of the Aberrant Copper Homeostasis Hypothesis
por: Amit Pal, et al.
Publicado: (2021)

Effects of an Atypical Antipsychotic, Zotepine, on Astroglial L-Glutamate Release through Hemichannels: Exploring the Mechanism of Mood-Stabilising Antipsychotic Actions and Antipsychotic-Induced Convulsion
por: Kouji Fukuyama, et al.
Publicado: (2021)

Regenerative Effects of CDP-Choline: A Dose-Dependent Study in the Toxic Cuprizone Model of De- and Remyelination
por: Viktoria Gudi, et al.
Publicado: (2021)

Amyloid-Beta Peptides and Activated Astroglia Impairs Proliferation of Nerve Growth Factor Releasing Cells In Vitro: Implication for Encapsulated Cell Biodelivery-Mediated AD Therapy
por: Sumonto Mitra, et al.
Publicado: (2021)

Pharmacological and Epigenetic Regulators of NLRP3 Inflammasome Activation in Alzheimer’s Disease
por: Francesca La Rosa, et al.
Publicado: (2021)

Study of Histopathological Lesions in CA1 of the Hippocampus after Injection of Beta-Amyloid in a Rat Model of Alzheimer’s Disease
por: SM Hoseini,, et al.
Publicado: (2012)

Differential Clearance of Aβ Species from the Brain by Brain Lymphatic Endothelial Cells in Zebrafish
por: Yun-Mi Jeong, et al.
Publicado: (2021)

Modeling clustered activity increase in amyloid-beta positron emission tomographic images with statistical descriptors
por: Shokouhi S, et al.
Publicado: (2015)

Liposome delivery systems for the treatment of Alzheimer’s disease
por: Ross C, et al.
Publicado: (2018)

Pharmacist-led interventions during transitions of care of older adults admitted to short term geriatric units: Current practices and perceived barriers
por: Véronique C. LeBlanc, et al.
Publicado: (2022)

Quantitative Brain Positron Emission Tomography in Female 5XFAD Alzheimer Mice: Pathological Features and Sex-Specific Alterations
por: Caroline Bouter, et al.
Publicado: (2021)

Nanoparticle-conjugated nutraceuticals exert prospectively palliative of amyloid aggregation
por: Kanubaddi KR, et al.
Publicado: (2018)

Machine Learning to Predict Brain Amyloid Pathology in Pre-dementia Alzheimer’s Disease Using QEEG Features and Genetic Algorithm Heuristic
por: Nam Heon Kim, et al.
Publicado: (2021)

Transferrin-Modified Osthole PEGylated Liposomes Travel the Blood-Brain Barrier and Mitigate Alzheimer’s Disease-Related Pathology in APP/PS-1 Mice
por: Kong L, et al.
Publicado: (2020)

Carbonic Anhydrases as Potential Targets Against Neurovascular Unit Dysfunction in Alzheimer’s Disease and Stroke
por: Nicole Lemon, et al.
Publicado: (2021)

Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics
por: Tiwari S, et al.
Publicado: (2019)

A hydrogel biosensor for high selective and sensitive detection of amyloid-beta oligomers
por: Sun LP, et al.
Publicado: (2018)

Peptide-Based Vaccines for Neurodegenerative Diseases: Recent Endeavors and Future Perspectives
por: Vyronia Vassilakopoulou, et al.
Publicado: (2021)

Isoorientin Inhibits Amyloid β<sub>25–35</sub>-Induced Neuronal Inflammation in BV2 Cells by Blocking the NF-κB Signaling Pathway
por: Buyun Kim, et al.
Publicado: (2021)

Targeting neuroinflammation in Alzheimer’s disease
por: Bronzuoli MR, et al.
Publicado: (2016)

Rhynchophylline Loaded-mPEG-PLGA Nanoparticles Coated with Tween-80 for Preliminary Study in Alzheimer’s Disease
por: Xu R, et al.
Publicado: (2020)

Amyloid-β 25-35 Induces Neurotoxicity through the Up-Regulation of Astrocytic System X<sub>c</sub><sup>−</sup>
por: Veronica D’Ezio, et al.
Publicado: (2021)